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Abstract
Background: Bipolar Disorder (BD) is a common and severe form of mental illness characterised by repeated relapses
of mania or depression. Pharmacotherapy is the main treatment currently offered, but this has only limited effectiveness.
A recent Cochrane review has reported that adding psycho-social interventions that train people to recognise and
manage the early warning signs of their relapses is effective in increasing time to recurrence, improving social functioning
and in reducing hospitalisations. However, the review also highlights the difficulties in offering these interventions within
standard mental health services due to the need for highly trained therapists and extensive input of time. There is a need
to explore the potential for developing Early Warning Sign (EWS) interventions in ways that will enhance dissemination.
Methods and design: This article describes a cluster-randomised trial to assess the feasibility of training care
coordinators (CCs) in community mental health teams (CMHTs) to offer Enhanced Relapse Prevention (ERP) to people
with Bipolar Disorder. CMHTs in the North West of England are randomised to either receive training in ERP and to
offer this to their clients, or to continue to offer treatment as usual (TAU). The main aims of the study are (1) to
determine the acceptability of the intervention, training and outcome measures (2) to assess the feasibility of the design
as measured by rates of recruitment, retention, attendance and direct feedback from participants (3) to estimate the
design effect of clustering for key outcome variables (4) to estimate the effect size of the impact of the intervention on
outcome. In this paper we provide a rationale for the study design, briefly outline the ERP intervention, and describe in
detail the study protocol.
Discussion: This information will be useful to researchers attempting to carry out similar feasibility assessments of
clinical effectiveness trials and in particular cluster randomised controlled trials.
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Background
Bipolar Disorder (BD) is a common and severe form of
mental illness characterised by repeated relapses of mania
or depression. Recurrence rates are high at around 50% at
one year and 70% at four years [1,2]. Pharmacotherapy is
the main treatment currently offered, but this has only
limited effectiveness [3]. Surveys of patient organisations
in the United States (US) and United Kingdom (UK)
reveal a strong wish by patients for both self-help and psy-
chological treatments in addition to pharmacotherapy
[4,5]. One form of intervention is to teach patients with
BD to recognise and manage early warning signs (EWS) of
mania and depressive episodes. A recent systematic review
of this approach found that 11 RCTs involving 1324
patients show the efficacy of interventions that include
this approach [6]. Overall, EWS interventions, in addition
to treatment as usual, increased time to recurrence and
reduced the percentage of people hospitalised. Despite
having no clear impact on depressive or manic inter-epi-
sode symptoms, there was some evidence that EWS inter-
ventions had a positive impact on levels of functioning.
Most of these studies reviewed involved interventions
consisting of extensive hours of therapy with highly
trained therapists, clearly restricting their generalisability
to current NHS services. The review highlights the need for
further research to explore cost-effective ways in which
these interventions can be offered within the NHS. Bauer
et al (2006) showed that positive outcomes for reducing
relapse into mania could be achieved within Veterans
Affairs hospitals in the US using a chronic care model in
which people are transferred to a specialist team provid-
ing group psychoeducation, improved pharmacotherapy
guidelines, and coordinated care to enhance communica-
tion within services [7,8]. Although demonstrated to be
cost-neutral, this intervention required setting up new
specialist bipolar disorder teams and the benefits for serv-
ice users were only apparent by the third year of being in
such a service [7]. Although designed to address issues of
external validity, generalising from these settings to the
UK NHS and probably other health settings is problem-
atic because there is no political will to provide brand new
services specifically and only for service users with BD [9].
However, there is political will to adapt existing services to
meet the needs of service users with BD more specifically.
The least resource intensive intervention in a UK study
was that by Perry et al (1999) in which a median of 9 ses-
sions were offered by a minimally trained research psy-
chologist in addition to treatment as usual (TAU) and
demonstrated a fourfold increase in time to next manic
episode in people receiving Relapse Prevention (RP) com-
pared to those receiving treatment as usual only, and a
30% reduction in number of manic episodes over 18
months[10]. The intervention did not detect an impact on
depressive episodes. This is likely to be due to greater dif-
ficulty in identifying EWS of depression, lack of clear cop-
ing strategies for these signs, and delay in response to anti-
depressant medication.
In this study we have devised an enhanced form of a RP
approach, which is enhanced by an increased focus on the
identification of EWS for depression, more detailed devel-
opment of coping strategies available for both depression
and mania, and the involvement of a relative/friend to
support the intervention where appropriate. The key ele-
ments of the ERP intervention are those explicitly recom-
mended by the NICE Guidelines for Bipolar Disorder [9],
and include psychoeducation, a detailed analysis of previ-
ous episodes, identification of trigger situations and early
warning signs, enhancing coping strategies for mood
changes, an action plan for responding to early warning
signs, and an agreement with clinical services about how
they will respond to different stages of relapse. These ele-
ments are done separately for mania, depression and
mixed episodes. The intervention is used alongside other
interventions such as pharmacotherapy.
In addition to the enhancements to the RP approach, this
study differs significantly from those described previously
(including Perry et al (1999)) in that the ERP intervention
will be offered to people with Bipolar Disorder by Care
Coordinators (CCs) currently working in Community
Mental Health Teams (CMHTs) in the National Health
Service (NHS). A CMHT is a multidisciplinary team of
health professionals (community mental health nurses,
occupational therapists, psychiatric social workers, clini-
cal psychologists and psychiatrists) working out of a team
base in the geographical locality the CMHT serves. The
CMHT sees service users at the base, other clinic bases or
in the home of the service user. All service users with seri-
ous mental illness whose needs require more than the
support of one professional group would be looked after
by a CMHT with one of the health professionals in the
team acting as a CC taking the lead role for coordinating
the care of the patient but not delivering all aspects of the
patient's care [11]. All service users in the CMHT will have
as a minimum a CC and a psychiatrist but there may also
be other members of the CMHT or other health or social
service professionals who would provide specific services
to the service user with BD. Hence, this study focuses on
issues related to the clinical effectiveness of relapse pre-
vention in a real world setting that uses existing CCs and
is able to examine the impact and the barriers that arise in
this situation. We are aiming to address the important
issue of transferring evidence-based interventions from
psychological research settings into NHS practice. Inter-
ventions that have been shown to be clinically efficacious
under ideal conditions may not be effective in clinical
practice [12]. The approach is consistent with the Depart-BMC Psychiatry 2007, 7:6 http://www.biomedcentral.com/1471-244X/7/6
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ment of Health remit for CMHTs to offer psychological
interventions aimed at preventing relapse in people with
severe mental illnesses ("such as schizophrenia and bipo-
lar disorder") and to work with both patients and carers
[11].
The approach relies on a quick and reliable response from
the CMHTs to changes in patients' symptoms and there-
fore the intervention must be offered by the team as a
whole, rather than by individual CCs. Once trained, these
teams would be unable to offer treatment as usual. Thus
in order to assess the effectiveness of the intervention, a
cluster randomised controlled trial (RCT) is needed in
which the CMHT is the unit of randomisation. Effective-
ness can be assessed at two levels; firstly, the effectiveness
of the training on the ability of the CCs to carry out the
key elements of the ERP interventions; secondly the effec-
tiveness of the CC delivered ERP intervention on reducing
relapse rates in people with Bipolar Disorder.
A large-scale evaluation of the effectiveness of the ERP
intervention is required. However, this is likely to be a
very expensive study due to the costs of training staff and
the recruitment, assessment and retention of large num-
bers of staff, service users and relatives. Therefore it is
important that the study is theoretically well designed,
methodologically feasible, adequately powered to iden-
tify any impact the intervention has on outcome, and well
executed. To enable this to happen, essential information
is required that will be obtained from this study. This
includes: an understanding of what current TAU is for
people with Bipolar Disorder who are offered a service by
CMHTs; acceptability of the ERP intervention, training
and supervision packages; effectiveness of training and
supervision on Care Coordinator competency and confi-
dence to offer ERP; recruitment and retention rates for
CMHTs, individual Care Coordinators, service users with
BD and relatives; acceptability, validity and reliability of
assessment measures including those modified for the
study; identification of major barriers to carrying out the
project within the NHS; an estimate of the effect size of
the intervention; an estimate of the design effect of clus-
tering. Detailed evaluation of process variables will allow
the mechanism of action to be understood so that impor-
tant inferences can be drawn in terms of the wider imple-
mentation of the intervention. This trial is an example of
a Phase II exploratory trial in the Medical Research Coun-
cil (MRC) framework for development and evaluation of
RCTs for complex interventions to improve health [13].
Reporting the details of the study design also contributes
to a widely recognised need for increased sharing of infor-
mation from pilot studies of cluster trials to improve
methodological developments in this area [14].
The aim of the trial is to assess the feasibility of a large
cluster randomised trial to evaluate the effectiveness of
training CCs in ERP for people with bipolar disorder.
The aim of this paper is to outline the ERP intervention,
provide a rationale for the study design, and describe in
detail the study protocol. Future papers will give a detailed
description of the intervention and the process of training
and will report on the feasibility and effectiveness of the
training and the impact of this on relapse rates for people
with Bipolar Disorder.
Methods
Structure of the trial
The trial is conducted by multidisciplinary researchers
based across 3 academic institutions, and CMHT staff
working in the NHS. The trial is funded by the Medical
Research Council and Merseycare NHS Trust, sponsored
by the University of Liverpool, and is supported by an
independent Trial Steering Committee consisting of serv-
ice users, researchers, clinicians and statisticians. Ethical
approval through Central Office for Research Ethics Com-
mittees (COREC) and Research & Development (R&D)
approval at each Trust has been given.
Design
ERP is a stratified cluster randomised controlled trial with
extensive evaluation of the process as well as the outcome
of the trial. CMHTs are randomly allocated to receive
training and supervision in ERP or to continue to offer
Treatment as Usual (TAU). The number of teams in each
Trust is identified prior to randomisation. The variable for
stratification is NHS Trust. This is to take into account dif-
ferent systems and approaches for working with Bipolar
Disorder between Trusts and also any changes in guide-
lines for working with BD that may appear during the
period of study. Teams are allocated numbers, which are
then randomised electronically. Service users with BD
from teams in both arms are assessed by researchers blind
to allocation on a range of outcome measures for up to 48
weeks following the onset of treatment. All incidences of
unblinding are recorded.
A cluster design is considered necessary because all mem-
bers of a CMHT need to be able to understand and imple-
ment an individual relapse prevention plan for all service
users. Although each service user has a named CC, other
members of the team are closely involved in their care
through out-of-hours cover, crisis management, co-work-
ing etc. Therefore any training aimed at modifying prac-
tice should be offered to teams rather than individuals.
Data from service users with Bipolar Disorder who are
within the same cluster i.e. seen by the same team, are not
independent. Other variables, such as team set-up, previ-
ous team training, management style, etc. are likely toBMC Psychiatry 2007, 7:6 http://www.biomedcentral.com/1471-244X/7/6
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influence the outcome of the intervention. Failing to
account for this clustering effect is may result in under-
powered studies [15].
Sample
Sample size
A power calculation is not applicable for this study. The
aim of the feasibility study is to collect information that
will allow us to estimate the effect size for ERP compared
to TAU and to estimate the impact of using a cluster ran-
domised design (intra-class correlation coefficient). This
information will allow a meaningful sample size calcula-
tion to be made for a large-scale definitive effectiveness
trial (Phase III within the MRC complex interventions
framework).
Inclusion/Exclusion criteria
All CMHTs across 4 North West NHS Trusts are invited to
take part in the trial. Specialist teams such as Assertive
Outreach Teams (AOTs), Crisis Teams, Home Treatment
Teams, and Early Intervention Teams are excluded.
Teams are included in the randomisation if a minimum of
4 CCs gives informed consent to take part in the study.
This includes agreeing to attend the training and supervi-
sion and to offer the intervention to a minimum of 3 serv-
ice users each if the team is allocated to ERP. CMHTs
working from the same building with extensive clinical
cover are entered as one team. This reduces the possibility
of any contamination between teams allocated to differ-
ent arms of the trial.
Staff with a range of backgrounds are invited to take part
in the training (nurses, occupational therapists, and social
workers), but must be identified Care Coordinators for
service users. Support workers are excluded from the study
but are invited to sit in on the training where resources
allowed.
Service users are invited to take part if they had a lifetime
diagnosis of Bipolar I or II, have experienced two or more
relapse ever and at least one in the last year or two in the
last three years, and are currently not in a major depres-
sive, hypomanic, manic or mixed episode in the last four
weeks. Service users are excluded if there is a clear organic
cause of their disorder, they have a rapid cycling disorder,
they have significant cognitive impairment, they have
alcohol/drug misuse as a primary diagnosis, they do not
have a working understanding of English language, or
they are unable or unwilling to give informed consent.
Recruitment and consent
All CMHTs in the participating NHS Trusts are given a ver-
bal presentation about the study and written information
sheets. A minimum of 4 CCs from each team are asked to
give written consent to invite service users into the study,
to attend the training and supervision if allocated to the
ERP arm of the trial, and to provide quantitative and qual-
itative feedback on the training and supervision.
Service users with a clinical diagnosis of Bipolar Disorder
are initially informed about the study by their CC. We
obtain lists of service users who would seem to meet the
inclusion/exclusion criteria for the study according to the
CMHT prior to the randomisation of teams to prevent any
bias in the numbers of service users who are recruited to
the two arms of the study. Recruitment occurring post-
randomisation of the CMHTs is noted and rates of recruit-
ment monitored to identify any post-randomisation
selection bias or impact on recruitment rates. Service users
are asked to consent to their contact details being passed
to the research team in order to receive more information
about the study. Those who consent are sent a letter and a
visit is arranged with a researcher who gives verbal and
written information about the study. Service users are
then asked to give written consent in two parts. The first
part consents them to take part in the data collection for
the study, and the second to take part in the clinical inter-
vention, if they are allocated to the ERP arm of the trial.
This ensures that participants who drop out of the inter-
vention, can still take part in the research study if they
wish [16].
Service users offered ERP are invited to involve a relative/
friend in the intervention. Where this occurs, the relative/
friend is asked by the CC to give written consent to take
part in the study. Following the intervention, the relative/
friend is invited to give qualitative feedback on their expe-
riences. Figure 1 gives an outline of the design of the
study.
The intervention
Enhanced relapse prevention
The intervention was initially devised by one of the
authors (RM) [17] and has been developed further for this
study by the PI (FL) one of the grant holders (PK) and the
trial therapist (LT). A detailed manual outlining the
rationale and process of the intervention is given to all
CCs and service users. This forms the basis of a collabora-
tive intervention.
Training and supervision
The training takes place over six 2-hour long sessions,
occurring approximately weekly. The training is offered in
NHS accommodation at a time and location most con-
venient to the teams being trained. The training follows
the six-session format of the intervention and the aim of
each session is to ensure the CCs understand the rationale
for the content of each session and feel able to work with
service users to achieve the session aims. The trainingBMC Psychiatry 2007, 7:6 http://www.biomedcentral.com/1471-244X/7/6
Page 5 of 9
(page number not for citation purposes)
includes a mixture of didactic information-giving, group
discussion, videoed role-play examples (using profes-
sional actors), and in-situ role play tasks.
Following the training, all CCs are offered weekly clinical
supervision for three months during which time they are
expected to offer the intervention to at least one service
user. The supervision is offered in groups consisting of
CCs from the same team. All of the training and supervi-
sion sessions are conducted by the trial therapist (LS). CCs
are asked to give feedback on the training and supervision.
At the end of the intervention with the first service user,
they are asked to rate their perceived competency and con-
fidence in offering the intervention. Each individual is
also rated by the trial therapist at the same time point.
Data collection and analysis
A breakdown of reasons for exclusion and reasons for
withdrawal from the training, intervention and follow-up
phases of the study will be provided (Figure 1). Table 1
Diagram showing Design of the Study Figure 1
Diagram showing Design of the Study.
CMHTs randomised
(stratified by Trust)
CCs trained in ERP CCs receive no
training Evaluation of
ERP training,
supervision ,
implementation
(CCs)
Evaluation of
TAU (CCs)
Service users with
Bipolar Disorder offered
ERP
Service users with
bipolar disorder
offered TAU
Baseline assessment
of service users with
BD
Baseline assessment
of service users with
BD
Followup assessment
at 12, 24, 36, 48 weeks
Followup assessment
at 12, 24, 36, 48 weeks
Evaluation of
intervention by
service users
and relatives)
CMHTs allocated
to ERP
CMHTs allocated
to TAU
Evaluation of
intervention by
service users
CMHTs assessed for
eligibility
Excluded
or refusedBMC Psychiatry 2007, 7:6 http://www.biomedcentral.com/1471-244X/7/6
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shows the timeframe for the assessments and measures
that are used with service users with Bipolar Disorder. All
measures are completed at face to face interview expect
where indicated otherwise. Interviews take place in the
service users' home, or a suitable NHS site.
Primary outcomes
The primary aims of the study are to assess the acceptabil-
ity and feasibility of the trial design, and to estimate the
effect size of the impact of the intervention on outcome.
Acceptability and feasibility
Recruitment, retention and attendance rates for CCs, serv-
ice users, and relatives will be reported. Likert scale ratings
of the quality of training and supervision and of CC com-
petence and confidence in using ERP will be analysed.
Barriers to carrying out the study at each stage will be iden-
tified and discussed and potential solutions identified.
Semi-structured in-depth interviews are conducted with a
subsample of Care Coordinators and service users from
each arm of the trial, and relatives involved in ERP. The
aims are to: explore experiences of care coordinators of
training and implementation of ERP within an NHS set-
ting; to identify factors involved in the implementation
and effectiveness of the ERP intervention for CC (at an
individual, team and organisational level), service users
and relatives or friends; to ascertain what TAU is for those
with Bipolar disorder as received/provided by their care
coordinators; and to explore the experiences of relatives/
friends of service provision and their role in the manage-
ment of Bipolar disorder.
A purposive maximum variation sampling strategy is
deployed for each interview group and is an iterative proc-
ess. Thus, on the basis of initial analysis, additional partic-
ipants are selected who are thought to be able to fill-in,
expand, or challenge previous data. At most 20 to 30 inter-
views will be conducted for each group although this may
vary if data saturation is obtained, or if vagaries of data
collection impede the attainment of theoretical satura-
tion. Data are analysed using a grounded theory [18]
approach. Following a constant comparative approach, an
initial coding frame is complied, which is refined and
elaborated in the light of incoming data and ongoing
analysis. The results of the qualitative analysis will be
reported elsewhere on completion of the trial.
Impact of the intervention on outcome
An estimate of the effect size of the intervention will be
made from a comparison of time from baseline to recur-
rence of an episode of major depression, hypomania,
Table 1: Schedule of Quantitative Assessments for Service Users
Assessment 0 weeks (baseline) 12 weeks 24 weeks 36 weeks (by telephone) 48 weeks
Primary Outcome measures
Hamilton Rating Scale for Depression + + + + +
Bech-Rafaelsen Mania Scale (MAS) + + + + +
Current mental state coding (SCID-I) + - - - -
Secondary Outcome measures
LIFE scores for mania and depression for current week + + + + +
Social and Occupational Functioning Assessment Scale (SOFAS) + + + - +
Client Service Receipt Inventory (CSRI) + - + - +
Process measures
# Early Warning Signs Checklist (Mania and Depression) + + + - +
# Coping strategies Checklist (Mania and Depression) + + + - +
# Brief Illness Perception Questionnaire for Bipolar Disorder (modified 
IPQ)
++ + - +
Potential confounds
Demographics + - - - -
Clinical data* + + + - +
Lifetime coding of mental illness (SCID-I) + - - - -
SCID-II coding for Borderline and Antisocial Personality Assessment + - - - -
Verona Service Satisfaction Scale (VSSS-EU) + - - - +
Relationship Quality Rating + + + - +
*Clinical data includes current medication, start and end dates of last episode and history of episodes over the previous 3 years.
# designed or significantly modified for this studyBMC Psychiatry 2007, 7:6 http://www.biomedcentral.com/1471-244X/7/6
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mania, or mixed, satisfying DSM-IV criteria [19] following
at least 8 weeks below this level for that pole. The number
and percentage of patients satisfying criteria for a DSM-IV
episode, broken down by type (major depression; mania
type; other), will be reported for each treatment group and
overall. The number and percentage of patients for whom
information is imputed will also be reported. The inter-
vals (in days) from baseline to recurrence (of any type)
will be summarised by Kaplan-Meier curves (plotted up to
48 weeks). Cox proportional hazard models with robust
variance estimators will be used to provide estimates of
the hazard ratios and 95% confidence intervals.
The main analyses will be conducted on all patients from
all teams (assigned to treatment groups (ERP and TAU) as
randomised), applying the principle of intention to treat
(ITT), as far as is practically possible, given any missing
data. Sensitivity analyses based on a "per protocol" (PP)
analysis will be conducted to examine robustness of the
main results to departure from intended trial treatment.
The sample of patients for the PP analyses is defined as the
sample for the ITT analyses minus those patients who
could not have received sufficient trial treatment due to
CCs not attending at least 4 training sessions, or service
users receiving less than 4 sessions of ERP. Given that the
study is a feasibility study used in part to estimate the sam-
ple size for a larger study, effect sizes with 95% confidence
intervals will be given weight rather than reliance on levels
of statistical significance alone.
Secondary outcomes
The effect of the intervention and the clustering design on
secondary outcome and process measures will be assessed
over 12 months. Secondary outcomes include symptom
severity, social and occupational functioning, and cost of
services received in each arm of the trial. Specific hypoth-
eses linked to these are that (1) ERP will improve outcome
compared to TAU by reducing the severity of symptoms;
(2) ERP will improve outcome compared to TAU by
improving social and occupational functioning; (3) there
will be no difference in the overall cost of services received
between those receiving ERP and those receiving TAU.
Whilst it is recognised that ERP may initially require addi-
tional contact with the CC, following the intervention,
service users who have received ERP will be better able to
manage their own mood changes and are less likely to
experience a relapse or require an admission to hospital.
Severity ratings of overall symptom levels based on the
LIFE-II (Longitudinal Interval Follow-up Evaluation) will
be obtained at weekly intervals post-baseline to 48 weeks.
These will be averaged over intervals of four weeks, sepa-
rately for depression and mania, and analysed by multi-
level modelling to allow for the repeated measures and
cluster design. Multilevel models will also be used to com-
pare social and occupational functioning and cost of serv-
ices, between groups.
Process measures
Measures will be used to try to understand the process by
which any changes occur. Process measures include recog-
nition of early warning signs of relapse, use of coping
strategies, and beliefs about mental health problems. Spe-
cific hypotheses linked to these measures are: (1) ERP will
improve outcome compared to TAU by increasing the fre-
quency of monitoring for early warning signs, and the
number of signs identified in the early phase of relapse.
(2) ERP will improve outcome compared to TAU by
increasing the number and perceived effectiveness of
appropriate coping strategies for managing early warning
signs of relapse (Coping Strategy Checklist (modified
from Lam & Wong 1997 [20]); (2) ERP will have a posi-
tive impact on service users beliefs about their mental
health problems (Brief Illness Perception Questionnaire
for Bipolar Disorder (modified from the IPQ Weinman et
al 1996 [21]). Multilevel models allowing for repeated
measures and cluster design will be used to compare mon-
itoring and recognition of early warning signs, use of cop-
ing strategies and beliefs about mental health problems
between the groups.
Potential confounds
A number of potential confounds have been identified on
the basis of previous work in this area including number
of previous episodes [22,23], amount of social support
[24] and use of medication [25]. These are assessed and
will be controlled for in the analyses.
Discussion
This study is essential in providing information necessary
to the planning and execution of a definitive evaluation of
the clinical effectiveness of relapse prevention approaches
for Bipolar Disorder in the NHS.
We have devised an enhanced form of a relapse preven-
tion approach that has already been shown to reduce
relapse rates for mania. The enhancements are designed
to: improve the effectiveness of the intervention at reduc-
ing rates of relapse into depression; make the intervention
more widely available by tailoring it specifically to be used
by CCs currently working in the NHS (rather than requir-
ing referral to specialist services); streamline the interven-
tion by identifying the key elements that can be offered in
six, one-hour sessions; involve a friend or relative which is
likely to increase the effectiveness of the intervention and
make it more acceptable to service users. This intervention
is highly consistent with the psychosocial components of
treatment recommended by the recent NICE Clinical
Guidelines for Bipolar Disorder [9].BMC Psychiatry 2007, 7:6 http://www.biomedcentral.com/1471-244X/7/6
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We have designed the feasibility study to provide as much
detailed and accurate information as possible. The inclu-
sion criteria for staff and for service users are as wide as
possible to increase generalisability. The manual and all
training materials are designed to a high standard and
quality for wider dissemination. Detailed feedback is
sought on the training and supervision. The service user
assessments include well standardised, valid and reliable
measures of the key outcome variables, along with exten-
sive qualitative interviews to explore the experiences of
participants in depth. The research team meet on a regular
basis to discuss and log barriers faced in conducting the
research and ideas for how these could be avoided/over-
come in future work. A detailed picture is obtained about
how the intervention is used in practice.
There are a number of important limitations to the study
that need to be addressed in future work. Firstly, this study
is designed to assess the impact of clustering at the level of
CMHT and to account for this in the statistical analysis of
outcome. However, in reality the study has 2 levels of clus-
tering: the CMHT and the Care Coordinator. Each Care
Coordinator is asked to offer the ERP intervention to a
minimum of 3 service users. It could be argued that data
from service users who receive the intervention from the
same Care Coordinator is likely to be correlated more
highly than that from different Care Coordinators within
the same team. However, due to the fact that the number
of people within each cluster at the CC level would be
likely to be very small i.e. 3, and the total sample would
be insufficient to explore multiple level clustering, this
will not be accounted for in the analysis.
Secondly, we have argued that a cluster design is required
because ERP is essentially a team approach. Service users
may need to be able to contact the CMHT at very short
notice in response to increased recognition of important
changes in their early signs of relapse. An effective and
reliable response from the team is essential. For this rea-
son, whichever CMHT staff member is currently on duty
should be able to work with the ERP plan. In reality, we
have recruited teams with a minimum of 4 CCs consent-
ing to take part. This is for purely pragmatic reasons. In
setting up the study, services felt unable to commit the
time and resources for all staff to attend. Although the
documentation regarding early signs monitoring and
action plans is available in the service users notes, future
work needs to address the best ways to disseminate infor-
mation within and between mental health teams. It is pos-
sible that this limitation will reduce the effectiveness of
the intervention.
Thirdly, due to the time constraints on the study, we are
unable to recruit all service users prior to randomisation
at each NHS Trust site. CCs make referrals throughout the
study and generally offer ERP sequentially to one person
at a time. Teams in TAU also make referrals throughout as
more people who are eligible are identified. We are assess-
ing and will report on whether or not this has led to a
recruitment bias.
Fourthly, we are not able to assess fidelity to the interven-
tion for all service users. The trial therapist makes a rating
of adherence to the manual for the service users who are
offered the intervention during the period of supervision.
However, after completing the first intervention, CCs are
offering ERP to service users outside of supervision. There
is no assessment of fidelity for these interventions.
These limitations are clearly important and need to be
addressed in future work. However, despite these, the
results from this study are essential in progressing research
and clinical innovation in this area. If we are able to show
that it is feasible to train CCs in the NHS to offer ERP for
people with Bipolar Disorder, it will be possible to design
a large scale definitive trial to evaluate the effectiveness of
the intervention on relapse rates. Such an intervention has
the potential to offer service users a way of increasing con-
trol over their mood disorder and ultimately improving
their quality of life and that of their relatives and friends.
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